EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mileage matters: long-distance performance of CARs in multiple myeloma

Eric M Jurgens, Saad Z Usmani, Maximilian Merz

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2025-012730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Eric M Jurgens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, B-Cell Maturation Antigen, Receptors, Chimeric Antigen, Neoplasm Recurrence, Local. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Deutsche Forschungsgemeinschaft, International Myeloma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting B-cell maturation antigen with chimeric antigen receptor (CAR) T-cells is a new standard of care in relapsed/refractory multiple myeloma (RRMM). However, long-term data have currently remained sparse. In a recent study published in the Journal for ImmunoTherapy of Cancer by Jin et al , authors reported on a large cohort of 141 patients with a median follow-up of 20.2 months. They found an overall response rate of 90.1% with 48.2% achieving a complete response. The median progression-free survival was 15.2 months, and the 4-year overall survival rate was 63.2%. In the current article, we summarize the published long-term data from clinically approved and investigational CAR T-cells for RRMM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaB-Cell Maturation AntigenReceptors, Chimeric AntigenNeoplasm Recurrence, LocalImmunotherapy, AdoptiveHumansProgression-Free SurvivalSurvival RateDrug Resistance, NeoplasmFollow-Up StudiesTime FactorsClinical Trials as Topic

Stichwörter der Autor:innen

Chimeric antigen receptor - CARMultiple Myeloma

Substanzen

B-Cell Maturation AntigenReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA maximilian.merz@medizin.uni-leipzig.de.
  • Leipzig University, Leipzig, Saxony, Germany.

Förderung

  • NCI NIH HHS
  • Deutsche Forschungsgemeinschaft
  • International Myeloma Society
  • EU HORIZON

Zitieren

APA

Jurgens, E. M., Usmani, S. Z., & Merz, M. (2025). Mileage matters: long-distance performance of CARs in multiple myeloma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012730

Vancouver

Jurgens EM, Usmani SZ, Merz M. Mileage matters: long-distance performance of CARs in multiple myeloma. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-012730

BibTeX
@article{Jurgens2025,
  author = {Jurgens, Eric M and Usmani, Saad Z and Merz, Maximilian},
  title = {Mileage matters: long-distance performance of CARs in multiple myeloma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2025-012730}
}
Kostenlos starten →